Skip to content

Study on the Central Mechanism of Acupuncture Modulation of Prefrontal-Amygdala Circuitry Subnetwork in Angina Pectoris based on fMRI-SpDCM

Study on the Central Mechanism of Acupuncture Modulation of Prefrontal-Amygdala Circuitry Subnetwork in Angina Pectoris based on fMRI-SpDCM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000971
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-04-21
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina

Interventions

Acupuncture group:Select bilateral Neiguan (PC-6) and Tongli (HT-5) acupoints and apply acupuncture therapy. Use the Park simulated needle device (Parksham device, PSD) combined with filiform needles,
Sham Acupuncture Group:Select bilateral Neiguan and Tongli acupoints and use sham acupuncture therapy. Use PSD combined with a retractable blunt needle
when the blunt needle contacts the skin, it retracts into the handle without penetrating the skin, without performing needle manipulation, and without achieving deqi, with a retention time of 30 minut
Healthy Control Group:not undergo acupuncture treatment.

Sponsors

Chongqing Changshou District Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for stable coronary artery disease as outlined in the "Guidelines for the Diagnosis and Treatment of Stable Coronary Artery Disease"; 2. Meets the CCS (Canadian Cardiovascular Society) grading criteria for angina severity, Grade I or II; 3. Age between 45 and 65 years (inclusive); 4. Disease duration of at least 3 months, with angina episodes occurring at least twice per week in the past month; 5. At least 2 months of history of standard basic drug therapy prior to enrollment (maintaining the same drugs, dosage, and administration); 6. Good compliance, willing to cooperate with the study, and patient has signed the informed consent form; 7. Right-handed.

Exclusion criteria

Exclusion criteria: 1. Pregnant and breastfeeding women, and those with plans to conceive within the next six months; 2. Individuals with severe primary diseases of the cardiovascular, digestive, urinary, respiratory, hematological, neurological, or endocrine systems that are not effectively controlled clinically; 3. Those who have progressed to acute coronary syndrome or severe arrhythmias; 4. Individuals with severe mental illness or intellectual disabilities who are unable to cooperate with questionnaire surveys; 5. Those with uncontrolled hypertension or diabetes; 6. Individuals who have undergone acupuncture treatment for cardiovascular diseases within the past month; 7. Those with a tendency to bleed or skin diseases; 8. Individuals currently participating in other clinical trials; 9. Conditions contraindicating MRI, such as the presence of metal implants or claustrophobia.

Design outcomes

Primary

MeasureTime frame
Frequency of angina pectoris episodes;Functional Magnetic Resonance Imaging (fMRI);

Secondary

MeasureTime frame
Visual Analog Scale score;Canadian Cardiovascular Society Angina Grading Criteria grading;Seattle Angina Questionnaire;Anxiety Self-Rating Scale;Depression Self-Rating Scale;Transcriptome sequencing;Metabolomics analysis;

Countries

China

Contacts

Public Contactchen lin

Chongqing Changshou District Traditional Chinese Medicine Hospital

85669650@qq.com02362520106

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026